C-reactive protein (CRP) is the most common serum biomarker of inflammation in IBD, and its characteristics are useful for grading inflammation, monitoring the response to therapy, and to identify recurrent inflammation after medically or surgically induced remission [20,32]. Here, CRP is linked to inflammatory bowel disease.